Re -Ding Pharmaceuticals rose more than 4%, Hang Seng Medical ETF (513060) fell slightly

In the afternoon, Hang Seng Medical ETF (513060) fell slightly, with a turnover of nearly 400 million yuan, and the traffic was active.Among the ingredients stocks, Ding Ding Pharmaceuticals and Nucheng Jianhua rose more than 4%, and Yongtai Bio, minimally invasive medical care, Aikang Medical care had risen by more than 3%; and Platinum Medicine and Pharmaceuticals fell more than 5%.

Yesterday, Zai Ding Pharmaceutical's midterm of the midterm showed that the company achieved a total revenue of US $ 94.9 million during the period, an increase of 66.38%year -on -year, and interest income of US $ 1.363 million, an increase of 197.60%year -on -year.The company stated that it will seek to accelerate the reading and registration of important data in the entire product portfolio in the future; continue to invest in research and development and promote the company's internal pipelines that have global rights; continue to expand the company's income foundation, and rely on potentially changing product pipelinesAnd cooperation opportunities to seek internal and external innovation.

China -Thailand Securities said that Zaiding Pharmaceutical Innovation Pharmaceutical Pipeline is rich in pipelines and strong product development capabilities. It has the potential to grow into a global large -scale innovative pharmaceutical company and maintain a "buy" rating.

- END -